Clinical Trials for Primary Hyperoxaluria Type 1 (PH1)

Find clinical trials for primary hyperoxaluria type 1 (ph1). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

NCT ID: NCT06839235

The redePHine study is a clinical trial that aims to test a new treatment called ABO-101 for people with Primary Hyperoxaluria Type 1 (PH1), a rare genetic condition that affects how the body proce...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, St. Paul, Minnesota, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions